Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
The Laryngoscope|August 2, 2008
Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptorsAndrew K Patel, Thomas H Alexander, Ali Andalibi, et al.
Biochemical Society Transactions|August 12, 2014
Endothelial cell oxidative stress in diabetes: a key driver of cardiovascular complications?Andrew Shaw, Mary K Doherty, Nicola J Mutch, et al.
The Annals of Otology, Rhinology, and Laryngology|March 22, 2024
Disparities in Sporadic Vestibular Schwannoma Initial Presentation Between a Public Safety Net Hospital and Tertiary Academic Medical Center at the Same Zip Code 2010 to 2020Raffaello M Cutri, Joshua Lin, Melissa L Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 1994
Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functionsJ M Eris, A Basten, R Brink, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|April 28, 2006
Meniere's disease: prevalence of contralateral ear involvementJohn W House, Joni K Doherty, Laurel M Fisher, et al.
Behavioural Brain Research|February 2, 2020
A proteomic signature for CNS adaptations to the valence of environmental stimulationAndrew Shaw, Luke D Arnold, Lucia Privitera, et al.
Irish Medical Journal|September 28, 2017
Association between psychological distress and cancer type in patients referred to a psycho-oncology serviceC Lavelle, M F Ismail, K Doherty, et al.
Irish Medical Journal|March 1, 1992
General practice estimates of the prevalence of common chronic conditionsR A Lyons, D Caroll, K Doherty, et al.
Journal of Proteome Research|October 29, 2008
Turnover of the human proteome: determination of protein intracellular stability by dynamic SILACMary K Doherty, Dean E Hammond, Michael J Clague, et al.
Oncogene|August 30, 2001
Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptorN G Azios, F J Romero, M C Denton, et al.
Pageof 16